Atlas Trials

A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm

Clinical trial NCT04766723 · COMPLETED

Trial details

NCT number
NCT04766723
Sponsor
Merz Pharmaceuticals GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Essential Tremor of the Upper Limb
Start date
2021-02-24
Primary completion
2023-04-26
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.